Bill caps insulin copays at $35 for insured patients starting 2028.
H.R. 10227 — INSULIN Act of 2026 · Filed by Diana DeGette (D-CO) · 11 cosponsors · Introduced Sep 2, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
The bill limits copays for insulin to $35 per month starting in 2028. It can go lower to 25% of the negotiated price if that costs less. It creates a resource center and hotline for uninsured people. These help patients find free insulin from manufacturers. The bill speeds up FDA approval of biosimilar insulins. The resource center gets $2 million per year from 2027 to 2032.
Who it affects
Insured patients with health plans gain lower copays for insulin. Uninsured patients get help finding free insulin from manufacturers. Biosimilar insulin makers get faster FDA approval for their products.
One thing to notice
The copay cap only covers certain insulin products that plans choose. Plans can still charge more for other insulin types.
From the analysis of the bill text, linked under Primary records below.
Where it stands
11 cosponsors: 8 Democrats, 3 Republicans.
- Sep 2, 2026 — Introduced · Congress.gov: “Introduced in House”
- Sep 2, 2026 — Referred to House Committee on Education and Workforce and House Committee on Ways and Means · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Words to know
- copay — The fixed amount a patient pays for medicine when they pick it up.
- biosimilar — A copy of a brand-name medicine made by a different company.
- negotiated price — The price a health plan agrees to pay for medicine.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (16,996 characters) on Sep 5, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 14,206 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-09-17.
“Bill caps insulin copays at $35 for insured patients starting 2028.” QuorumCivic. https://share.quorumcivic.app/bill/119/hr10227/simple Report an error